FRE:F-Fresenius SE & Co. KGaA (EUR)

COMMON STOCK | Medical Care Facilities | F

Last Closing Price

EUR 37.44

Change

-0.21 (-0.56)%

Market Cap

EUR 24.79B

Volume

3.03K

Avg Analyst Target

EUR 46.25 (+23.53%)

Avg User Target

EUR
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Fresenius SE & Co. KGaA (FRE) Stock Analysis:
Based on the Fresenius SE & Co. KGaA stock forecasts from 4 analysts, the average analyst target price for Fresenius SE & Co. KGaA is EUR 46.25 over the next 12 months. Fresenius SE & Co. KGaA’s average analyst rating is . Stock Target Advisor’s own stock analysis of Fresenius SE & Co. KGaA is Bullish , which is based on 7 positive signals and 3 negative signals. At the last closing, Fresenius SE & Co. KGaA’s stock price was EUR 37.44. Fresenius SE & Co. KGaA’s stock price has changed by +0.66% over the past week, +2.92% over the past month and -2.40% over the last year.

About

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care Germany and internationally. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
2BH:F HCA Healthcare Inc

+2.60 (+1.18%)

EUR69.77B 12.93 7.26
FME:F Fresenius Medical Care AG & Co..

+2.00 (+3.42%)

EUR17.22B 18.76 7.44
TRL:F DaVita Inc

+1.05 (+1.05%)

EUR10.35B 13.42 7.79
RMY:F Ramsay Health Care Limited

N/A

EUR9.75B 34.98 8.92
UHS:F Universal Health Services Inc

+0.85 (+0.73%)

EUR9.32B 10.69 6.27
THC1:F Tenet Healthcare Corporation

+2.32 (+3.38%)

EUR7.58B 7.94 4.57
CXM:F Chemed Corporation

N/A

EUR6.52B 25.04 15.41
OPA:F Orpea SA

+1.04 (+1.19%)

EUR5.71B 30.55 17.05
7RA:F Acadia Healthcare Company Inc

+0.40 (+0.81%)

EUR4.59B 39.36 12.75
4NM1:F China Evergrande New Energy Ve..

+0.02 (+3.71%)

EUR4.50B 725.00 N/A

ETFs Containing FRE

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.88% 93% A 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.88% 93% A 78% C+
Trailing 12 Months  
Capital Gain -2.40% 43% F 34% F
Dividend Return 2.29% 90% A- 62% D-
Total Return -0.10% 44% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.64% 36% F 35% F
Dividend Return 1.15% 63% D 18% F
Total Return 2.79% 36% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 6.99% 96% A 92% A-
Risk Adjusted Return 39.87% 51% F 51% F
Market Capitalization 24.79B 98% A+ 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.18 83% B 64% D
Price/Book Ratio 1.04 84% B 75% C
Price / Cash Flow Ratio 3.79 70% C- 49% F
EV/EBITDA 6.87 71% C- 53% F
Management Effectiveness  
Return on Equity 9.83% 57% F 55% F
Return on Invested Capital 9.29% 78% C+ 74% C
Return on Assets 3.74% 50% F 59% F
Debt to Equity Ratio 99.24% 37% F 25% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.31 24% F 31% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.